Candidate malaria vaccine provides lasting protection in NIH-sponsored trials
Candidate malaria vaccine provides lasting protection in NIH-sponsored trials Approach could have role in preventing…
News Releases
News Releases
Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen
Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard…
News Releases
Novel vaccine concept generates immune responses that could produce multiple types of HIV broadly neutralizing antibodies
Novel vaccine concept generates immune responses that could produce multiple types of HIV broadly neutralizing…
News Releases
NIH-sponsored trial of nasal COVID-19 vaccine opens
NIH-sponsored trial of nasal COVID-19 vaccine opens Candidate vaccine could provide enhanced breadth of protection…